Form D · Other

Kingsmore Biotech, LLC

Miami Beach, FL · CIK 0001701426

Offering snapshot reported Jul 18, 2017 · SEC filing

Reported sold
$478K
Offering amount: $478K
Investors reported
41
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Mar 17, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$239K$478KApr 3, 2017: $345,900.00Apr 3, 2017Jul 18, 2017: $478,400.00Jul 18, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$345,900 → $478,400
  • Reported investors31 → 41

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 18, 2017Amendment$478,400$132,500vs Apr 3, 201741SEC filing
Apr 3, 2017Initial$345,900No comparison31SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-283925
Membership interest % in LLC

Source: Form D, filed Jul 18, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kelley Dalby Director
Alex Nemiroff Director

Issuer details

Industry: Other (See others in industry)

Address:
5251 Lagorce Drive
Miami Beach, FL, 33140